From: Differences in gene mutations according to gender among patients with colorectal cancer
Men | Women | |||
---|---|---|---|---|
Gender | ||||
Men | 990 | 65.8% | ||
Women | 515 | 34.2% | ||
Age (years) | p < 0.001 | |||
Median(range) | 72.17 | 28~ 107 | 73.95 (28~ 107) | 67.20 (31~ 95) |
≤ 70 years | 646 | 42.9% | 355 (35.9%) | 291 (56.5%) |
> 70 years | 859 | 57.1% | 635 (64.1%) | 224 (43.5%) |
Pathological staging | p = 0.011 | |||
I | 212 | 14.1% | 132 (13.3%) | 80 (15.5%) |
II | 564 | 37.5% | 399 (40.3%) | 165 (32.0%) |
III | 473 | 31.4% | 291 (29.4%) | 182 (35.3%) |
IV | 256 | 17.0% | 168 (17.0%) | 88 (17.1%) |
Tumor localization | p < 0.0001 | |||
Right colon | 400 | 26.6% | 232 (23.4%) | 168 (32.6%) |
Left colon and rectum | 1105 | 73.4% | 758 (76.6%) | 347 (67.4%) |
Histopathology grade | p = 0.368 | |||
Well and moderately differentiated | 1417 | 94.2% | 936 (94.5%) | 481 (93.4%) |
Poorly differentiated | 88 | 5.8% | 54 (5.5%) | 34 (6.6%) |